» Articles » PMID: 37830058

The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D Agonist [18F]MCL-524

Overview
Date 2023 Oct 13
PMID 37830058
Authors
Affiliations
Soon will be listed here.
Abstract

The dopamine D agonist MCL-524 is selective for the D receptor in the high-affinity state (D), and, therefore, the PET analogue, [F]MCL-524, may facilitate the elucidation of the role of D in disorders such as schizophrenia. However, the previously reported synthesis of [F]MCL-524 proved difficult to replicate and was lacking experimental details. We therefore developed a new synthesis of [F]MCL-524 using a "non-anhydrous, minimally basic" (NAMB) approach. In this method, [F]F is eluted from a small (10-12 mg) trap-and-release column with tetraethylammonium tosylate (2.37 mg) in 7:3 MeCN:HO (0.1 mL), rather than the basic carbonate or bicarbonate solution that is most often used for [F]F recovery. The tosylated precursor (1 mg) in 0.9 mL anhydrous acetonitrile was added directly to the eluate, without azeotropic drying, and the solution was heated (150 °C/15 min). The catechol was then deprotected with the Lewis acid In(OTf) (10 equiv.; 150 °C/20 min). In contrast to deprotection with protic acids, Lewis-acid-based deprotection facilitated the efficient removal of byproducts by HPLC and eliminated the need for SPE extraction prior to HPLC purification. Using the NAMB approach, [F]MCL-524 was obtained in 5-9% RCY (decay-corrected, = 3), confirming the utility of this improved method for the multistep synthesis of [F]MCL-524 and suggesting that it may applicable to the synthesis of other F-labeled radiotracers.

References
1.
Seeman P . Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets. 2006; 10(4):515-31. DOI: 10.1517/14728222.10.4.515. View

2.
Skinbjerg M, Sibley D, Javitch J, Abi-Dargham A . Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?. Biochem Pharmacol. 2011; 83(2):193-8. PMC: 3610415. DOI: 10.1016/j.bcp.2011.09.008. View

3.
Nakata Y, Kanahara N, Iyo M . Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice. J Psychopharmacol. 2017; 31(12):1511-1518. DOI: 10.1177/0269881117728428. View

4.
Kniess T, Laube M, Steinbach J . "Hydrous F-fluoroethylation" - Leaving off the azeotropic drying. Appl Radiat Isot. 2017; 127:260-268. DOI: 10.1016/j.apradiso.2017.06.010. View

5.
Seeman M, Seeman P . Is schizophrenia a dopamine supersensitivity psychotic reaction?. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 48:155-60. PMC: 3858317. DOI: 10.1016/j.pnpbp.2013.10.003. View